Don't discount GSK23 Jun 2021 10:07
GSK have a pipeline to fill. Patents are up soon on a number of multi billion money making drugs. GSK need to replace these drugs. They will be announcing today, according to several newspaper reports, that they are looking at cutting their divi in favour of funding their R&D. Hal Barron GSK's CSO & President, R&D and Luke Miels, COO are both in the UK today for the GSK announcement. GSK is certainly one to watch. They also have deep pockets and are under pressure to deliver.